0

Although widely used, pharmacotherapeutic approaches to the treatment of post-traumatic stress disorder (PTSD) have been undermined by uncertainty about efficacy. Hoskins et al (pp. 93–100) systematically reviewed the relevant literature and found that selective serotonin reuptake inhibitors (SSRIs) appear to be superior to placebo in reducing PTSD symptoms but with a small associated effect si...

Poor compliance can reduce the efficacy of treatments, resulting in worse health outcomes for patients. Using a randomised design, Gray et al (pp. 157–162) trained community psychiatric nurses for 80 hours in medication management. Independent researchers interviewed their patients and the patients of nurses who did not receive training, at recruitment and 6 months later. Patients who were care...